A SEER analysis of >9K women with stage IA hormone receptor-positive HER2-negative breast cancer demonstrates, while 55% omitted post-lumpectomy radiation, only 13% omitted axillary surgery—with 5+ years of hormone deprivation presumably recommended for all—once again highlighting the need for the breast oncology community to make wholistic efforts at de-escalating treatment in a patient-centric manner, particularly with 5-day partial breast irradiation in mind. | Minami, JAMA Netw Open 2024
